Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free

Mandeep Bajaj1, Rafael Medina-Navarro, Swangjit Suraamornkul

  • 1School of Life Sciences, Arizona State University, P.O. Box 874501, Tempe, AZ 85287-4501, USA.

Diabetes
|March 1, 2007
PubMed

Insights

Reducing lipid levels in insulin-resistant individuals improved glucose uptake but did not reverse all molecular changes. Muscle gene expression shifts suggest complex responses to lipid reduction, not always correlating with insulin sensitivity improvements.

Area of Science:

  • Metabolic diseases
  • Molecular biology
  • Exercise physiology

Background:

  • Lipid oversupply contributes to skeletal muscle insulin resistance.
  • It reduces mitochondrial gene expression and increases extracellular matrix remodeling.
  • Understanding if lipid reduction reverses these changes is crucial for type 2 diabetes research.

Purpose of the Study:

  • To investigate the effects of decreased plasma lipid content on insulin resistance markers in skeletal muscle.
  • To determine if reducing free fatty acids reverses molecular abnormalities in insulin-resistant individuals.

Main Methods:

  • Used euglycemic clamps and muscle biopsies in insulin-resistant subjects with a family history of type 2 diabetes.
  • Administered acipimox to suppress plasma free fatty acids.
  • Analyzed changes in glucose disposal, intramuscular fatty acyl CoA, and gene expression.

Main Results:

  • Acipimox significantly reduced free fatty acids and increased glucose disposal.
  • Intramuscular fatty acyl CoA levels decreased markedly.
  • Paradoxically, expression of PGC-1 and nuclear-encoded mitochondrial genes decreased, while collagen and growth factor expression increased.

Conclusions:

  • Reduced lipid supply does not fully reverse molecular changes in skeletal muscle associated with lipid oversupply.
  • Changes in nuclear-encoded mitochondrial gene expression may not consistently correlate with insulin sensitivity.
  • These findings highlight the complexity of metabolic adaptations in insulin resistance.

Related Concept Videos

Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...